Cargando…
Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
BACKGROUND: We estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission. METHODS: We enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522480/ https://www.ncbi.nlm.nih.gov/pubmed/37752066 http://dx.doi.org/10.1111/irv.13185 |
_version_ | 1785110363998519296 |
---|---|
author | Gallagher, Katherine E. Nyiro, Joyce Agoti, Charles N. Maitha, Eric Nyagwange, James Karani, Angela Bottomley, Christian Murunga, Nickson Githinji, George Mutunga, Martin Ochola‐Oyier, Lynette Isabella Kombe, Ivy Nyaguara, Amek Kagucia, E. Wangeci Warimwe, George Agweyu, Ambrose Tsofa, Benjamin Bejon, Philip Scott, J. Anthony G. Nokes, David James |
author_facet | Gallagher, Katherine E. Nyiro, Joyce Agoti, Charles N. Maitha, Eric Nyagwange, James Karani, Angela Bottomley, Christian Murunga, Nickson Githinji, George Mutunga, Martin Ochola‐Oyier, Lynette Isabella Kombe, Ivy Nyaguara, Amek Kagucia, E. Wangeci Warimwe, George Agweyu, Ambrose Tsofa, Benjamin Bejon, Philip Scott, J. Anthony G. Nokes, David James |
author_sort | Gallagher, Katherine E. |
collection | PubMed |
description | BACKGROUND: We estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission. METHODS: We enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood sample, and naso‐oropharyngeal swabs were collected. Household members were followed 4, 7, 10, 14, 21 and 28 days after the date of the first PCR‐positive in the household; naso‐oropharyngeal swabs were collected at each visit and used to define secondary cases. Blood samples were collected every 1–2 weeks. Symptoms were collected in a daily symptom diary. We used binomial regression to estimate secondary attack rates and survival analysis to analyse risk factors for transmission. RESULTS: A total of 119 households with at least one positive household member were enrolled between October 2020 and September 2022, comprising 503 household members; 226 remained in follow‐up at day 14 (45%). A total of 43 secondary cases arose within 14 days of identification of the primary case, and 81 household members remained negative. The 7‐day secondary attack rate was 4% (95% CI 1%–10%), the 14‐day secondary attack rate was 28% (95% CI 17%–40%). Of 38 secondary cases with data, eight reported symptoms (21%, 95% CI 8%–34%). Antibody to SARS‐CoV‐2 spike protein at enrolment was not associated with risk of becoming a secondary case. CONCLUSION: Households in our setting experienced a lower 7‐day attack rate than a recent meta‐analysis indicated as the global average (23%–43% depending on variant), and infection is mostly asymptomatic in our setting. |
format | Online Article Text |
id | pubmed-10522480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105224802023-09-28 Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study Gallagher, Katherine E. Nyiro, Joyce Agoti, Charles N. Maitha, Eric Nyagwange, James Karani, Angela Bottomley, Christian Murunga, Nickson Githinji, George Mutunga, Martin Ochola‐Oyier, Lynette Isabella Kombe, Ivy Nyaguara, Amek Kagucia, E. Wangeci Warimwe, George Agweyu, Ambrose Tsofa, Benjamin Bejon, Philip Scott, J. Anthony G. Nokes, David James Influenza Other Respir Viruses Original Articles BACKGROUND: We estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission. METHODS: We enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood sample, and naso‐oropharyngeal swabs were collected. Household members were followed 4, 7, 10, 14, 21 and 28 days after the date of the first PCR‐positive in the household; naso‐oropharyngeal swabs were collected at each visit and used to define secondary cases. Blood samples were collected every 1–2 weeks. Symptoms were collected in a daily symptom diary. We used binomial regression to estimate secondary attack rates and survival analysis to analyse risk factors for transmission. RESULTS: A total of 119 households with at least one positive household member were enrolled between October 2020 and September 2022, comprising 503 household members; 226 remained in follow‐up at day 14 (45%). A total of 43 secondary cases arose within 14 days of identification of the primary case, and 81 household members remained negative. The 7‐day secondary attack rate was 4% (95% CI 1%–10%), the 14‐day secondary attack rate was 28% (95% CI 17%–40%). Of 38 secondary cases with data, eight reported symptoms (21%, 95% CI 8%–34%). Antibody to SARS‐CoV‐2 spike protein at enrolment was not associated with risk of becoming a secondary case. CONCLUSION: Households in our setting experienced a lower 7‐day attack rate than a recent meta‐analysis indicated as the global average (23%–43% depending on variant), and infection is mostly asymptomatic in our setting. John Wiley and Sons Inc. 2023-09-26 /pmc/articles/PMC10522480/ /pubmed/37752066 http://dx.doi.org/10.1111/irv.13185 Text en © 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Gallagher, Katherine E. Nyiro, Joyce Agoti, Charles N. Maitha, Eric Nyagwange, James Karani, Angela Bottomley, Christian Murunga, Nickson Githinji, George Mutunga, Martin Ochola‐Oyier, Lynette Isabella Kombe, Ivy Nyaguara, Amek Kagucia, E. Wangeci Warimwe, George Agweyu, Ambrose Tsofa, Benjamin Bejon, Philip Scott, J. Anthony G. Nokes, David James Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study |
title | Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study |
title_full | Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study |
title_fullStr | Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study |
title_full_unstemmed | Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study |
title_short | Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study |
title_sort | symptom prevalence and secondary attack rate of sars‐cov‐2 in rural kenyan households: a prospective cohort study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522480/ https://www.ncbi.nlm.nih.gov/pubmed/37752066 http://dx.doi.org/10.1111/irv.13185 |
work_keys_str_mv | AT gallagherkatherinee symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT nyirojoyce symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT agoticharlesn symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT maithaeric symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT nyagwangejames symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT karaniangela symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT bottomleychristian symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT murunganickson symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT githinjigeorge symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT mutungamartin symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT ocholaoyierlynetteisabella symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT kombeivy symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT nyaguaraamek symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT kaguciaewangeci symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT warimwegeorge symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT agweyuambrose symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT tsofabenjamin symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT bejonphilip symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT scottjanthonyg symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy AT nokesdavidjames symptomprevalenceandsecondaryattackrateofsarscov2inruralkenyanhouseholdsaprospectivecohortstudy |